Molecular Diagnosis and Pathway Convergence in Neurodevelopmental Disorders: An Integrative Genomic Study of 1,011 Patients
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background Genetic factors are critical to diagnosing neurodevelopmental disorders (NDDs). Despite advances in genetic diagnostics, a considerable proportion of patients remain undiagnosed, highlighting the urgent need to identify underlying genetic etiologies and discover additional pathogenic genes and molecular mechanisms. Method Whole-exome sequencing (WES), trio-WES, panel sequencing, chromosomal microarray analysis (CMA), or multiplex ligation-dependent probe amplification (MLPA) were used for identifying potential variant. Comprehensive clinical and laboratory data were collected. All patients were classified into 18 phenotypic subgroups. GWAS was conducted for sequencing-negative cases. Results Of the 1011 patients with GDD/ID, the most comorbid symptoms were abnormal MRI findings, craniofacial malformations, and malnutrition/feeding difficulties/growth retardation. The overall diagnostic rate was 54% (508/940), with 343(36.5%) single-nucleotide variations (SNVs) and 157(16.7%) Copy number variants (CNVs). Among SNV-positive cases, we identified 166/430(38.6% ) novel variants and 179/430 (41.6%) de novo variants. In CNV-positive cases, the top recurrent cytobands were 15q11.2-q13.1, Xq28, and 7q11.2. GWAS analysis showed that genetically negative cases were significant enrichment in the Rap1 signaling and O-glycosylation modification, while positive cases significantly enriched in axonogenesis and chromatin remodeling. Integrated analysis of two sets highlighted convergence on O-glycosylation and calcium response. Protein-protein interaction analysis of 47 overlapping genes identified the RAS-MAPK signaling pathway. Conclusion: Our findings further supported the clinical value of trio-WES/WES as a first-tier diagnostic strategy for NDDs. Importantly, O-glycosylation modification emerges as a critical molecular mechanism in NDDs, offering a potential convergence may reveal common neurobiological processes.
